Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
castration-resistant prostate cancer (CRPC) Male Hormonal Therapies Question 10.2
CDA
CDC
CDK inhibitors antiapoptotic proteins cell cycle and transcription
CDKs
central nervous system (CNS) Answer 11.1 Answer 2.2 Anticancer Drug Development: An Introduction
cerebrospinal fluid (CSF) Anticancer Drug Development: An Introduction Transplant-Related Agents
cGVHD
checkpoint inhibitors (CPIs) anti-tumor immunity immune-related adverse effects multiple cancers management Multiple Myeloma as a Paradigm for Multi-Targeted Intervention
checkpoint kinase 1 (CHK1)
chimeric antigen receptor (CAR) Immunotherapeutics Including Vaccines, Bispecifics, CAR-T, and Checkpoint Inhibitors Multiple Myeloma as a Paradigm for Multi-Targeted Intervention T-cell therapy
CHK1
cHL
chloroacetaldehyde (CAA)
chronic graft-versus-host disease (cGVHD)
chronic lymphocytic leukemia (CLL) Antimetabolites: Hydroxyurea, Pyrimidine and Purine Analogs, and L-Asparaginase DNA Repair, Apoptotic Pathways, CDK Inhibitors Question 3.1 Targeted Therapies (Small Molecules)
chronic myeloid leukemia (CML)
CJD
cladribine, cytarabine, and filgrastim with mitoxantrone (CLAG-M) Answer 3.2 Question 3.7
CLAG-M
classic Hodgkin's lymphoma (cHL)
Clinical trials
CLL
CLS
Cmax
CML
CMP
CNS
College of American Pathologists (CAP)
Common Terminology Criteria for Adverse Events (CTCAE)